10 July 2024
10 July 2024
Post-acquisition, Vivo Infusion will oversee 80 ambulatory infusion centres spread across 15 states in the US.
The upgrade work is anticipated to begin later this year and is projected to be finished by the end of next year.
The acquisition, valued at approximately Rs750m, is anticipated to be completed within one month.
The project includes constructing a 11-story tower, expanding ER, and transitioning to a 100% private-room facility.
This move is set to alleviate documentation load, boost compliance, and potentially increase reimbursement for eligible members.
The move, funded by the president's American Rescue Plan, will address mental health and substance use challenges faced by women.
Upon completion, the upgraded hospital will be equipped to handle 18,000 more emergency patients annually.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
